A role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis
B cells are key mediators of humoral immunity. Mature B cells fall into various sub-classes that can be separated by their ontogeny, expression of cell surface markers, anatomical location, and function. B1 subsets play important roles in natural immunity and constitute the majority of B cells in ne...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 845235 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
16.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | B cells are key mediators of humoral immunity. Mature B cells fall into various sub-classes that can be separated by their ontogeny, expression of cell surface markers, anatomical location, and function. B1 subsets play important roles in natural immunity and constitute the majority of B cells in newborns. In the adult, B1 cells predominate in the pleural and peritoneal cavities, while the mature B2 follicular subset makes up the major fraction of B cells in lymphoid tissue, although important subsets of antibody-secreting B1 cells are also present at these sites. B1 cells are the main producers of natural IgM but can also contribute to elimination of some pathogens, while B2 cells primarily mediate response to foreign antigens. The differential molecular underpinning of the B1 and B2 subsets remains incompletely understood. Here we demonstrate that germline-deficiency of the orphan nuclear receptor NR2F6 causes a partial loss of B1b and B2 B cells in the peritoneum while leaving peritoneal B1a cells unaltered. A competitive bone marrow chimera in
Nr2f6
+/+
host mice produced similar numbers of
Nr2f6
+/+
and
Nr2f6
-/-
peritoneal B1b and B2 cells. The proliferation of
Nr2f6
-/-
peritoneal B cells was not altered, while the migration marker CXCR5 was reduced on all subsets but Beta7-integrin was reduced only on peritoneal B1b and B2 cells. Similarly, B1b and B2 but not B1a cells, exhibited significantly reduced survival. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Bojana Jakic, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden Edited by: Subbarao Bondada, University of Kentucky, United States Reviewed by: Nichol E. Holodick, Western Michigan University, United States; Eliver Ghosn, Emory University, United States This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2022.845235 |